BEAM Beam Therapeutics28.57+1.32 (+4.8%)
BEAM Beam Therapeutics34.03+5.42 (+18.9%)
BEAM Beam Therapeutics22.86-0.44 (-1.9%)
BEAM Beam Therapeutics23.85-2.46 (-9.4%)
Premarket Decliner
BEAM Beam Therapeutics24.36+1.43+6.2%
Premarket:19.40-4.96 (-20.4%)
Beam Therapeutics Reports Third Quarter 2024 Financial Results and Progress Across Priority Programs
Globe NewswireTue, 5-Nov 6:30 AM
BEAM Beam Therapeutics30.32+3.27 (+12.1%)